85 related articles for article (PubMed ID: 9374103)
1. Future directions of paclitaxel-based therapy of breast cancer.
Gianni L
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-91-S17-96. PubMed ID: 9374103
[TBL] [Abstract][Full Text] [Related]
2. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
Hudis CA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
[TBL] [Abstract][Full Text] [Related]
3. Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.
Seidman AD; Hudis CA; Fennelly D; Raptis G; Baselga J; Norton L
Semin Oncol; 1995 Oct; 22(5 Suppl 12):108-16. PubMed ID: 7481852
[TBL] [Abstract][Full Text] [Related]
4. The pharmacoeconomics of cancer therapies.
Bishop JF; Macarounas-Kirchman K
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
Paridaens R
Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
7. Management of breast cancer: status and future trends.
Hortobagyi GN
Semin Oncol; 1995 Oct; 22(5 Suppl 12):101-7. PubMed ID: 7481851
[TBL] [Abstract][Full Text] [Related]
8. Review and outlook for the role of paclitaxel in urothelial carcinoma.
Vaughn DJ
Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793
[TBL] [Abstract][Full Text] [Related]
9. Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.
Lu CH; Lin YC; Chang HK
Chang Gung Med J; 2007; 30(1):33-40. PubMed ID: 17477027
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of esophageal cancer.
Weiner LM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel pharmacology and other tumor types.
Rowinsky EK
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
[TBL] [Abstract][Full Text] [Related]
14. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
[TBL] [Abstract][Full Text] [Related]
15. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
Shin DM; Lippman SM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
Rincon M; Broadwater G; Harris L; Crocker A; Weaver D; Dressler L; Berry D; Sutton L; Michaelson R; Messino M; Kirshner J; Fleming G; Winer E; Hudis C; Appel S; Norton L; Muss H;
Breast Cancer Res Treat; 2006 Dec; 100(3):301-8. PubMed ID: 16773437
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer response to paclitaxel in vivo.
Symmans FW
Drug Resist Updat; 2001 Oct; 4(5):297-302. PubMed ID: 11991683
[TBL] [Abstract][Full Text] [Related]
19. Concurrent paclitaxel and radiation therapy for breast cancer.
Formenti SC; Symmans WF; Volm M; Skinner K; Cohen D; Spicer D; Danenberg PV
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):34-42. PubMed ID: 10210538
[TBL] [Abstract][Full Text] [Related]
20. Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.
Henderson IC; Bhatia V
Expert Rev Anticancer Ther; 2007 Jul; 7(7):919-43. PubMed ID: 17627452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
